Piramal Life Sciences Ltd, part of the Piramal Group of companies in Mumbai, commenced a phase I clinical study of P1736 drug in Netherlands.
The company announced that it got approval of Clinical Trial application from the Netherlands regulatory agency, the Central Commission on Medical Research Involving Human Subjects (CCMO) and the Independent Ethics Committee of the Foundation Evaluation of Ethics in Biomedical Research (BEBO). They will test this on 72 healthy volunteers, to meet the primary objective of determining
the safety and tolerance of P1736.
P1736 are new, orally active glucose-lowering compound specially for type II diabetic patients. This compound are different from other current marketed drugs, as this does not have any adverse side effects on liver function, blood plasma volume expansion or those related to weight gain.
The company also added that “An oral presentation of the pre=clinical data on this compound will be made at the forthcoming congress of the American Diabetes Association (ADA), to be convened in June at San Francisco, California, USA”
Source: The Economic Times
Filed under Diabetes, Diabetes Drug, Heart | Tags: American Diabetes Association, BEBO, California, CCMO, P1736, Piramal Life Sciences Ltd, type II diabetic | Comment Below
Related?
Clinical trial proves positive for diabetes drug by Sangamo BioSciencesSeptember 16th, 2008 On the basis of the clinical trial, Sangamo BioSciences Inc. is been successful in making the diabetes drug helping the problem of blocked nerves in lower limbs.
NIH Funded Clinical Trial for Islet Cell Transplantation for Type 1 Diabetes Cure StartedMay 19th, 2008 Here is a good news for those millions of type 1 diabetes patients. The NIH has decided to fund the clinical study that will focus on the new treatment to transplant the islet into the diabetes patients for improvement and long lasting blood sugar control.
Genera's promising drug to treat diabetes and obesity simultaneouslyFebruary 16th, 2009 The drug, Trodusquemine manufactured by leading biopharmaceutical company Genera is a highly selective inhibitor of PTP1B. The preliminary Phase 1b clinical trial of this medicine for the treatment of diabetes and obesity has proved to be highly successful.
Diabetes drug found to provide protective effects against multiple sclerosisMay 27th, 2009 WASHINGTON - University of Illinois researchers have observed that an FDA-approved drug, which is currently in use for diabetes treatment, shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis. This finding is based on a small, double-blinded clinical trial in which patients with relapsing remitting multiple sclerosis were assigned to take the drug pioglitazone or a placebo.
Researchers Reverse Juvenile Diabetes in Mouse - FDA Approves Clinical TrialMarch 29th, 2006 Researcher Massimo Trucco at Children's Hospital of Pittsburgh have observed marked amelioration of diabetes in a mouse model by a novel treatment strategy involving specific modification of the animal's own dendritic cells, thereby reversing diabetes in animal studies. The U.S. Food and Drug Administration (FDA) approved the start of a clinical trial to evaluate the safety and feasibility of the treatment.
Australian Study Provides Major Breakthrough In Diabetes TreatmentAugust 18th, 2008 In a major breakthrough in the medical science and research, the Australian researchers have developed a device to with a promise to make an end to diabetes and its related diseases like heart disease and other illnesses. The researchers have told that so far, there is no drug in the market to control the element fibrosis.
Nigerian scientist discovers wonder drug for diabetesFebruary 5th, 2009 A miraculous happening in the continent of Africa and world at the large !! Scientist Louis Obyo Obyo Nelson, doctorate in Molecular and Computational Chemistry from the University of Ibadan has eventually discovered a deadly weapon to slay one of the most dangerous, life - threatening killer disease in the world of researches and technology namely DIABETES. Nelson had been granted a United States patent entitled "Medicament for the Treatment of Diabetes".
New study to test the efficacy of arthritis drug in the treatment of diabetesFebruary 25th, 2009 Diabetes, characterized by abnormal blood glucose levels, is a chronic disorder leading to several complications like cardiovascular disease, blindness, kidney disease, amputations etc. People with diabetes die at rates two to four times higher than those who do not have it.
